Polasek_Tom

Dr Tom Polasek

Royal Adelaide Hospital Clinical Pharmacology Registrar

More from this expert

Clinical Articles iconClinical Articles

Despite potential savings of more than $1 billion annually, awareness of pharmacogenomic tests among Australian prescribers is low and national guidelines for their use have not been developed. This void contributes directly to the continued prescribing of ineffective medications, unacceptably high rates of adverse drug reactions and associated personal and economic costs.Pharmacogenomics (PGx) is the study of how the genome of an individual patient influences their response to a medication.

Despite potential savings of more than $1 billion annually, awareness of pharmacogenomic tests among Australian prescribers is low and national guidelines for their use have not been developed. This void contributes directly to the continued prescribing of ineffective medications, unacceptably high rates of adverse drug reactions and associated personal and economic costs.Pharmacogenomics (PGx) is the study of how the genome of an individual patient influences their response to a medication.

Clinical Articles iconClinical Articles

Upcoming Healthed Webcast

Tuesday 16th September, 7pm - 9pm AEST

Speaker

A/Prof Nicole Goh

Respiratory & Sleep Physician

We invite you to our next free webcast, where A/Prof Nicole Goh discusses the current state of play of the screening program and the likelihood of detecting non-lung cancer abnormalities. Earn up to 4 hours CPD. Accredited with RACGP and ACRRM.